• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research on tissue regeneration regulated by Met/HGF receptor ON-OFF regulation

Research Project

Project/Area Number 20390077
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field General medical chemistry
Research InstitutionKanazawa University

Principal Investigator

MATSUMOTO Kunio  Kanazawa University, がん研究所, 教授 (90201780)

Co-Investigator(Renkei-kenkyūsha) NAKAMURA Takahiro  金沢大学, がん研究所, 助教 (70414018)
SAKAI Katsuya  金沢大学, がん研究所, 助教 (10523318)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥19,760,000 (Direct Cost: ¥15,200,000、Indirect Cost: ¥4,560,000)
Fiscal Year 2010: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2009: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2008: ¥8,320,000 (Direct Cost: ¥6,400,000、Indirect Cost: ¥1,920,000)
Keywords細胞増殖因子 / HGF / 組織再生 / 受容体 / 再生医学 / Met / シグナル伝達 / チロシンキナーゼ / ノックアウトマウス / 肝再生 / 形態形成
Research Abstract

HGF-Met pathway participates in tissue regeneration. We found that phosphorylation of Ser985 in the Met receptor regulated dynamics and translocalization of Met, thereby regulating HGF-dependent Met activation. Ser985 phosphorylation was regulated upon liver injury, in a reciprocal manner to Met activation. Phosphorylation and dephosphorylation of Met-Ser985 regulated by tissue injury and intactness may play a role to suppress over-regeneration.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (156 results)

All 2011 2010 2009 2008 Other

All Journal Article (91 results) (of which Peer Reviewed: 86 results) Presentation (44 results) Book (14 results) Remarks (1 results) Patent(Industrial Property Rights) (6 results)

  • [Journal Article] HGF-Antagonists : Structure, Activities, and Anti-cancer Approach.2011

    • Author(s)
      Sakai K, Nakamura T, Kinoshita T, Nakamura T, Matsumoto K.
    • Journal Title

      Current Signal Transduction Therapy 6

      Pages: 191-199

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor twenty years on : much more than a growth factor.2011

    • Author(s)
      Nakamura T, Sakai K, Nakamura T, Matsumoto K.
    • Journal Title

      J.Gastroenterol. Hepatol. 26

      Pages: 188-202

    • NAID

      120003141437

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Induction of donor-specific tolerance using superagonistic CD28 antibody in rat renal allografts: Regulatory T-cell expansion before engraftment may be important.2011

    • Author(s)
      Azuma H, Isaka Y, Nomi H, Inamoto T, Li XK, Hounig T, Takabatake Y, Ichimaru N,Ibuki N, Matsumoto K, Ubai T, Katsuoka Y, Takahara S.
    • Journal Title

      Transplantation 90(12)

      Pages: 1328-1335

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Recombinant human HGF, but not rat HGF, elicits glomerular injury and albuminuria in normal rats via an immune complex-dependent mechanism.2011

    • Author(s)
      Mizuno S, Ikebuchi F, Fukuta K, Kato T, Matsumoto K, Adachi K, Nakamura T.
    • Journal Title

      Clin Exp Pharmacol Physiol. 38

      Pages: 192-201

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.2011

    • Author(s)
      Donev IS, Wang W, Yamada T, Li Q, Takeuchi S, Matsumoto K, Yamori T, Nishioka Y, Sone S, Yano S.
    • Journal Title

      Clin Cancer Res. 17(8)

      Pages: 2260-2269

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Cellular injury of cardiomyocytes during hepatocyte growth factor gene transfection with ultrasound-triggered bubble liposome destruction.2011

    • Author(s)
      Komamura, K., Tatsumi, R., Tsujita-Kuroda, Y., Onoe, T., Matsumoto, K., Nakamura, T., Miyazaki, J., Horio, T., Sugimachi, M.
    • Journal Title

      J.Drug Delivery 2011

      Pages: 1-8

    • NAID

      120004898438

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Cellular injury of cardiomyocytes during hepatocyte growth factor gene transfection with ultrasound-triggered bubble liposome destruction.2011

    • Author(s)
      Komamura K, Tatsumi R, Tsujita-Kuroda Y, Onoe T, Matsumoto K, Nakamura T, Miyazaki J, Horio T, Sugimachi M.
    • Journal Title

      J Drug Delivery

      Volume: 2011 Pages: 1-8

    • NAID

      120004898438

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor twenty years on: much more than a growth factor.2011

    • Author(s)
      Nakamura T, Sakai K, Nakamura T, Matsumoto K.
    • Journal Title

      J Gastroenterol Hepatol

      Volume: 26 Pages: 188-202

    • NAID

      120003141437

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Induction of donor-specific tolerance using superagonistic CD28 antibody in rat renal allografts : Regulatory T-cell expansion before engraftment may be important.2011

    • Author(s)
      Azuma H, Isaka Y, Nomi H, Inamoto T, Li XK, Hounig T, Takabatake Y, Ichimaru N, Ibuki N, Matsumoto K, Ubai T, Katsuoka Y, Takahara S.
    • Journal Title

      Transplantation

      Volume: 90 Pages: 1328-1335

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Recombinant human HGF, but not rat HGF; elicits glomerular injury and albuminuria in normal rats via an immune complex-dependent mechanism.2011

    • Author(s)
      Mizuno S, Ikebuchi F, Fukuta K, Kato T, Matsumoto K, Adachi K, Nakamura T.
    • Journal Title

      Clin Exp Pharmacol Physiol

      Volume: 38 Pages: 192-201

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Transient PI3K inhibition induces apoptosis and overcomes IIGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.2011

    • Author(s)
      Donev IS, Wang W, Yamada T, Li Q, Takeuchi S, Matsumoto K, Yamori T, Nishioka Y, Sone S, Yano S.
    • Journal Title

      Clin Cancer Res

      Volume: 17 Pages: 2260-2269

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] HGF-antagonists : structure, activities, and anti-cancer approach.2011

    • Author(s)
      Sakai K, Nakamura T, Kinoshita T, Nakamura T, Matsumoto, K.
    • Journal Title

      Current Signal Transduction Therapy

      Volume: (in press)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Anti-cancer approach with NK4 : Bivalent action and mechanisms.2010

    • Author(s)
      Nakamura T, Sakai K, Nakamura T, Matsumoto K.
    • Journal Title

      Anti-Cancer Agent Med. Chem. 10(1)

      Pages: 36-46

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Facilitated tendon-bone healing by local delivery of recombinant hepatocyte growth factor in rabbits.2010

    • Author(s)
      Nakase J, Kitaoka K, Matsumoto K, Tomita K.
    • Journal Title

      Arthroscopy 26

      Pages: 84-90

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor reduces susceptibility to an irreversible epigdermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.2010

    • Author(s)
      Yamada T, Matsumoto K, Wang W, Li Q, Nishioka Y, Sekido Y, Sone S, Yano S.
    • Journal Title

      Clin.Cancer Res. 16

      Pages: 174-183

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] p27 Nuclear localization and growth arrest caused by perlecan knockdown in human endothelial cells.2010

    • Author(s)
      Sakai K, Oka K, Matsumoto K, Nakamura T.
    • Journal Title

      Biochem.Biophys.Res.Commun. 392

      Pages: 403-408

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] hTERT-promotrt-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells.2010

    • Author(s)
      Onimaru M, Ohuchida K, Mizumoto K, Nagai E, Cui L, Toma H, Takayama K, Matsumoto K, Hashizume M, Tanaka M.
    • Journal Title

      Cancer Sci. 101

      Pages: 735-742

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.2010

    • Author(s)
      Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H, Nakamura T, Matsumoto K.
    • Journal Title

      Int.J.Cancer 127

      Pages: 1948-1957

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells.2010

    • Author(s)
      Onimaru M, Ohuchida K, Egami T, Mizumoto K, Nagai E, Cui L, Toma H, Matsumoto K, Hashizume M, Tanaka M.
    • Journal Title

      Cancer Gene Ther. 17

      Pages: 541-549

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Facilitated tendon-bone healing by local delivery of recombinant hepatocyte growth factor in rabbits.2010

    • Author(s)
      Nakase J, Kitaoka K, Matsumoto K, Tomita K.
    • Journal Title

      Arthroscopy

      Volume: 26 Pages: 84-90

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibition in EGFR-T790M mutant lung cancer.2010

    • Author(s)
      Yamada T, Matsumoto K., Wang W, Li Q, Nishioka Y, Sekido Y, Sone S, Yann S
    • Journal Title

      Clin Cancer Res.

      Volume: 16 Pages: 174-183

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] p27 Nuclear localization and growth arrest caused by perlecan knockdown in human endothelial cells.2010

    • Author(s)
      Sakai K Oka K, Matsumoto K, Nakamura T.
    • Journal Title

      Biochcm.Biophys.Res.Commun.

      Volume: 3 Pages: 403-408

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-detective adenovirus vectors in pancreatic cancer cells.2010

    • Author(s)
      Onimaru M, Ohuchida K, Mizumoto K, Nagai E, Cui L, Toma I-{, Takayama K, Matsumoto K, Hashizume M, Tanaka M.
    • Journal Title

      Cancer Sci.

      Volume: 101 Pages: 735-742

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Anti-cancer approach with NK4 : Bivalent action and mechanisms.2010

    • Author(s)
      Nakamura T, Sakai K, Nakamura T,Matsumoto K.
    • Journal Title

      Anti-cancer Agent Med.Chem.

      Volume: 10 Pages: 36-46

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.2010

    • Author(s)
      Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H, Nakamura T, Matsumoto K.
    • Journal Title

      Int.J.Cancer

      Volume: 127 Pages: 1948-1957

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells.2010

    • Author(s)
      Onimaru M, Ohuchida K. Egami T, Mizumoto K, Nagai E, Cui L. Toma H, Matsumoto K, Hashizume M, Tanaka M.
    • Journal Title

      Cancer Gene Ther

      Volume: 17 Pages: 541-549

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Facilitated tendon-bone healing by local delivery of recombinant hepatocyte growth factor in rabbits2010

    • Author(s)
      Nakase J, Matsumoto K, et al.
    • Journal Title

      Arthroscopy 26

      Pages: 84-90

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibition in EGFR-T790M mutant lung cancer2010

    • Author(s)
      Yamada T, Matsumoto K, et al.
    • Journal Title

      Clin Cancer Res. 16

      Pages: 174-183

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] p27 Nuclear localization and growth arrest caused by perlecan knockdown in human endothelial cells2010

    • Author(s)
      Sakai K, Matsumoto K, et al.
    • Journal Title

      Biochem.Biophys.Res.Commun. 3

      Pages: 403-408

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells2010

    • Author(s)
      Onimaru M, Matsumoto K, et al.
    • Journal Title

      Cancer Sci. 101

      Pages: 735-742

    • NAID

      10026589785

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Anti-cancer approach with NK4 : Bivalent action and mechanisms2010

    • Author(s)
      Nakamura T, Matsumoto K, et al.
    • Journal Title

      Anti-cancer Agent Med. Chem. 10

      Pages: 36-46

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.2010

    • Author(s)
      Suzuki Y, Matsumoto K, et al.
    • Journal Title

      Int.J.Cancer (印刷中)

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Angioinhibitory Action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association.2009

    • Author(s)
      Sakai K, Nakamura T, Matsumoto K, Nakamura T.
    • Journal Title

      J.Biol.Chem. 284

      Pages: 22491-22499

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice.2009

    • Author(s)
      Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, Matsumoto K, Nakamura T.
    • Journal Title

      Mol.Brain 2

      Pages: 8-8

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor prevents multiple organ injuries in endotoxemic mice through a heme oxygenase-1-dependent mechanism.2009

    • Author(s)
      Kamimoto M, Mizuno S, Matsumoto K, Nakamura T.
    • Journal Title

      Biochem.Biophys.Res.Commun. 380

      Pages: 333-337

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models.2009

    • Author(s)
      Kishi Y, Kuba K, Nakamura T, Wen J, Suzuki Y, Mizuno S, Nukiwa T, Matsumoto K, Nakamura T.
    • Journal Title

      Cancer Sci. 100

      Pages: 1351-1358

    • NAID

      10027192650

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.2009

    • Author(s)
      Kadoyama K, Funakoshi H, Ohya-Shimada W, Nakamura T, Matsumoto K, Matsuyama S, Nakamura T.
    • Journal Title

      Neurosci.Res. 65

      Pages: 194-200

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Different reactivities of enzyme-linked immunosorbent assays for hepatocyte growth factor.2009

    • Author(s)
      Fukuta K, Adachi E, Matsumoto K, Nakamura, T.
    • Journal Title

      Clinica Chimica Acta 402

      Pages: 42-46

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes.2009

    • Author(s)
      Liu KX, Kato Y, Matsumoto K, Nakamura T, Kaku T, Sugiyama Y.
    • Journal Title

      Pharm. Res. 26

      Pages: 1012-1021

    • NAID

      120001063570

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer.2009

    • Author(s)
      Egami T, Ohuchida K, Miyoshi K, Mizumoto K, Onimaru M, Toma H, Sato N, Matsumoto K, Tanaka M.
    • Journal Title

      Cancer Sci. 100

      Pages: 722-729

    • NAID

      10025144686

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] NK4, an HGF ntagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.2009

    • Author(s)
      Kubota T, Fujiwara H, Matsumura A, Taiyoh H, Ichikawa I, Okamoto K, Matsumoto M, Nakamura T, Otsuji E.
    • Journal Title

      Clin.Exp.Metastasis 26

      Pages: 447-456

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Up-regulation of integrin-b3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy.2009

    • Author(s)
      Egami T, Ohuchida K, Yasui T, Mizumoto K, Onimaru M, Toma H, Sato N, Matsumoto K, Tanaka M.
    • Journal Title

      Cancer Sci. 100

      Pages: 1902-1907

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T-lymphocyte activation.2009

    • Author(s)
      Kubota T, Taiyoh H, Matsumura A, Murayama Y, Ichikawa D, Okamoto O, Fujiwara H, Ikoma H, Nakanishi N, Kikuchi S, Ochiai T, Sakakura C, Kokuba Y, Suzuki Y,Matsumoto K, Nakamura T, Otsuji E.
    • Journal Title

      Int.J.Cancer. 125

      Pages: 2879-2886

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin.2009

    • Author(s)
      Tamase A, Muraguchi T, Naka K, Tanaka S, Kinoshita M, Hoshii T, Ohmura M, Ooshio T, Nakada M, Sawamoto K, Matsumoto K, Oshima M, Asano M, Saya H, Okano H,Suda T, Hamada J, Hirao A.
    • Journal Title

      Proc.Natl Acad.Sci.USA 106(40)

      Pages: 17163-17168

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Crosstalk to stromal fibroblasts induces resistance of lung cancer to EGFR tyrosine kinase inhibitors.2009

    • Author(s)
      Wang W, Li Q, Matsumoto K, Kayano Y, Matsumoto I, Oda M, Watanabe G, Nishioka Y, Sone S, Yano S.
    • Journal Title

      Clin.Cancer Res. 15(21)

      Pages: 6630-6638

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association2009

    • Author(s)
      Sakai K, Matsumoto K, et al.
    • Journal Title

      J.Biol.Chem. 284

      Pages: 22491-22499

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice2009

    • Author(s)
      Kanai M, Matsumoto K, et al.
    • Journal Title

      Molecular Brain 2

      Pages: 1-8

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin.2009

    • Author(s)
      Tamase A, Matsumoto K, et al.
    • Journal Title

      Proc Natl.Acad.Sci.USA 106

      Pages: 17163-17168

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Crosstalk to stromal fibroblasts induces resistance of lung cancer to EGFR tyrosine kinase inhibitors.2009

    • Author(s)
      Wang W Li, Matsumoto K, et al.
    • Journal Title

      Clin Cancer Res. 15

      Pages: 6630-6638

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Different reactivities of enzyme-linked immunosorbent assays for hepatocyte growth factor2009

    • Author(s)
      Fukuta K, Matsumoto K, et al.
    • Journal Title

      Clinica Chimica Acta 402

      Pages: 42-46

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes2009

    • Author(s)
      Liu KX, Matsumoto K, et al.
    • Journal Title

      Pharm.Res. 26

      Pages: 1012-1021

    • NAID

      120001063570

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor prevents multiple organ injuries in endotoxemic mice through a heme oxygenase-1-dependent mechanism2009

    • Author(s)
      Kamimoto M, Matsumoto K, et al.
    • Journal Title

      Biochem.Biophys.Res.Commun. 380

      Pages: 333-337

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer2009

    • Author(s)
      Egami T, Matsumoto K, et al.
    • Journal Title

      Cancer Sci. 100

      Pages: 722-729

    • NAID

      10025144686

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models2009

    • Author(s)
      Kishi Y, Matsumoto K, et al.
    • Journal Title

      Cancer Sci. 100

      Pages: 1351-1358

    • NAID

      10027192650

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells2009

    • Author(s)
      Kubota T, Matsumoto K, et al.
    • Journal Title

      Clin.Exp.Metastasis 26

      Pages: 447-456

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of transgenic mouse model of ALS2009

    • Author(s)
      Kadoyama K, Matsumoto K, et al.
    • Journal Title

      Neurosci.Res. 65

      Pages: 194-200

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Up-regulation of integrin-β3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy2009

    • Author(s)
      Egami T, Matsumoto K, et al.
    • Journal Title

      Cancer Sci. 100

      Pages: 1902-1907

    • NAID

      10027195795

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T-lymphocyte activation2009

    • Author(s)
      Kubota K, Matsumoto K, et al.
    • Journal Title

      Int.J.Cancer 125

      Pages: 2879-2886

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article]2009

    • Author(s)
      中村隆弘, 極本邦夫, 他
    • Journal Title

      がん分子標的治療Vol. 7 No. 2(メディカルレビュー社)

      Pages: 92-101

    • Related Report
      2009 Annual Research Report
  • [Journal Article]2009

    • Author(s)
      福田一弘, 松本邦夫, 他
    • Journal Title

      「バイオ医薬開発技術とシーズ」(山本重夫監修)(シーエムシー出版)

      Pages: 66-78

    • Related Report
      2009 Annual Research Report
  • [Journal Article]2009

    • Author(s)
      中村隆弘, 松本邦夫
    • Journal Title

      炎症・再生医学事典(朝倉書店)

      Pages: 518-521

    • Related Report
      2009 Annual Research Report
  • [Journal Article]2009

    • Author(s)
      鈴木芳典, 松本邦夫
    • Journal Title

      Surgery Frontier vol. 16(メディカルレビュー社)

      Pages: 466-470

    • Related Report
      2009 Annual Research Report
  • [Journal Article] Different reactivities of enzyme-linked immunosorbent assays for hepatocyte growth factor.2009

    • Author(s)
      Fukuta K, Matsumoto K, et al.
    • Journal Title

      Clinica Chimica Acta 402

      Pages: 42-46

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes.2009

    • Author(s)
      Liu KX, Matsumoto K, et al.
    • Journal Title

      Pharm. Res. 26

      Pages: 1012-1021

    • NAID

      120001063570

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyle growth factor prevents multiple organ injuries in endotoxemic mice through a he me oxygenase-1-dependentmechanism.2009

    • Author(s)
      Kamimoto M, Matsumolo K, et al.
    • Journal Title

      Biochem. Biophys. Res. Commun. 380

      Pages: 333-337

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] HGF anlagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.2009

    • Author(s)
      Kubola T, Matsumolo K, et al.
    • Journal Title

      Clin. Exp. Metastasis (In press)

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models.2009

    • Author(s)
      Kishi Y, Matsumolo K, el al.
    • Journal Title

      Cancer Sci. (In press)

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Tryptophan 2, 3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice.2009

    • Author(s)
      Kanai M, Matsumoto K, et al.
    • Journal Title

      Mol. Brain (In press)

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] HGF研究の進展と制癌剤開発2009

    • Author(s)
      中村隆弘, 松本邦夫
    • Journal Title

      がん分子標的治療(メディカルレビュー社) 7

      Pages: 92-101

    • Related Report
      2008 Annual Research Report
  • [Journal Article] NK4 gene therapy targeting HGF-Met and angiogenesis.2008

    • Author(s)
      Matsumoto K, Nakamura T.
    • Journal Title

      Front Biosci. 13

      Pages: 1943-1951

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] The functions and possible significance of Kremen as the gatekeeper of Wnt signaling in development and pathology.2008

    • Author(s)
      Nakamura T, Nakamura T, Matsumoto K.
    • Journal Title

      J.Cell.Mol.Med. 12

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor as a renotrophic and anti-fibrotic regulator in chronic renal disease.2008

    • Author(s)
      Mizuno S, Matsumoto K, Nakamura T.
    • Journal Title

      Front.Biosci. 13

      Pages: 7072-7086

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte Growth Factor and Met in Tumor Biology and Therapeutic Approach with NK4.2008

    • Author(s)
      Matsumoto K, Nakamura T, Sakai K, Nakamura T.
    • Journal Title

      Proteomics 8

      Pages: 3360-3370

    • NAID

      120001130499

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Generation of engineered recombinant hepatocyte growth factor cleaved and activated by Genenase I.2008

    • Author(s)
      Hayata D, Fukuta K, Matsumoto K, Adachi E, Hanada K, Adachi K, Nakamura T.
    • Journal Title

      J Biotechnol. 133

      Pages: 478-485

    • NAID

      120000811714

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with EGF Receptor activating mutations.2008

    • Author(s)
      Yano S, Wang W, Li Q, Matsumoto K, Sakurama H, Nakamura T, Ogino H, Kakiuchi S, Hanibuchi M, Nishioka Y, Uehara H, Mitsudomi T, Yatabe Y, Nakamura T, Sone S.
    • Journal Title

      Cancer Res. 68

      Pages: 9479-9487

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Regulation of cell migration and cytokine production by HGF-like protein (HLP)/macrophage stimulating protein (MSP) in primary microglia.2008

    • Author(s)
      Suzuki Y, Funakoshi H, Machide M, Matsumoto K, Nakamura T.
    • Journal Title

      Biomed.Res. 29

      Pages: 77-84

    • NAID

      130004724052

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor improves synaptic localization of the NMDA receptor and intracellular signaling after excitotoxic injury in cultured hippocampal neurons.2008

    • Author(s)
      Akita H, Takagi N, Ishihara N, Takagi K, Murotomi K, Funakoshi H, Matsumoto K, Nakamura T, Takeo S.
    • Journal Title

      Exp Neurol. 210(1)

      Pages: 83-94

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Growth factors temporally associate with airway responsiveness and inflammation in allergen-exposed mice.2008

    • Author(s)
      Ito W, Tanimoto M, Ono K, Mizuno S, Yoshida A, Koga H, Fuchimoto Y, Kondo N, Tanimoto Y, Kiura K, Matsumoto K, Kataoka M, Nakamura T, Gelfand E, Kanehiro A.
    • Journal Title

      Int.Arch.Allergy Immunol. 145

      Pages: 324-339

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation.2008

    • Author(s)
      Kiyama S, Yamada T, Iwata H, Sekino T, Matsuo H, Yoshida N, Miyahara T, Umeda Y, Matsuno Y, Kimura M, Matsumoto K, Nakamura T, Takemura H.
    • Journal Title

      J.Gastroenterol.Hepatol. 23

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.2008

    • Author(s)
      Egami T, Ohuchida K, Mizumoto K, Onimaru M, Toma H, Nishio S, Nagai E, Matsumoto K, Nakamura T, Tanaka M.
    • Journal Title

      Clin.CancerRes. 14

      Pages: 1859-1867

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Generation of engineered recombinant hepalocyte growth factor cleaved and activated by Generase I.2008

    • Author(s)
      Hayata D, Matsumoto K, et al.
    • Journal Title

      J. Biotechnol. 133

      Pages: 478-485

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The functions and possible significance of Kremen as the gatekeeper of Wnt signaling in development and palhology.2008

    • Author(s)
      Nakamura T, Malsumolo K, et al.
    • Journal Title

      J. Cell. Mol. Med. 12

      Pages: 391-408

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] NK4 gene therapy targeting HGF-Met and angiogenesis.2008

    • Author(s)
      Matsumolo K, et al.
    • Journal Title

      Front Biosci. 13

      Pages: 1943-1951

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepalocyle growth factor as a renolrophic and anti-fibrolic regulator in chronic renal disease2008

    • Author(s)
      Mizuno S, Matsumolo K, et al.
    • Journal Title

      Front. Biosci. 13

      Pages: 7072-7086

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte Growth Factor and Mel in Tumor Biology and Therapeutic Approach with NK4.2008

    • Author(s)
      Matsumoto K, et al.
    • Journal Title

      Proteomics 8

      Pages: 3360-3370

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor improves synaptic localizalion of the NMDA receptor and inlracellular signaling after excitoloxic injury in cultured hippocampal neurons.2008

    • Author(s)
      Akita H, Matsumolo K, el al.
    • Journal Title

      Exp Neurol. 210

      Pages: 83-94

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Growth factors temporally associate with airway responsiveness and inflammation in allergen-exposed mice.2008

    • Author(s)
      Ito W, Matsumoto K, et al.
    • Journal Title

      Int. Arch. Allergy Immunol. 145

      Pages: 324-339

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Regulation of cell migration and cytokine production by HGF-like protein (HLP)/macrophage stimulating protein (MSP)in primary microglia.2008

    • Author(s)
      Suzuki Y, Matsumoto K, et al.
    • Journal Title

      Biomed. Res. 29

      Pages: 77-84

    • NAID

      130004724052

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation.2008

    • Author(s)
      Kiyama S, Matsumoto K, et al.
    • Journal Title

      J. Gastroenterol. Hepatol. 23

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.2008

    • Author(s)
      Egami T, Matsumoto K, et al.
    • Journal Title

      Clin. Cancer Res. 14

      Pages: 1859-1867

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor induces gefltinib resistance of lung adenocarcinoma with EGF Receptor activating mutations.2008

    • Author(s)
      Yano S, Matsumoto K, et al.
    • Journal Title

      Cancer Res. 68

      Pages: 6479-6487

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Presentation] Functional analysis of the Kremen in Lewis lung carcinoma cells throughWnt/b-catenin signaling pathway.2010

    • Author(s)
      Xu Q, Fujikawa M, Nakamura T, Matsumoto K
    • Organizer
      第33回日本分子生物学会年会・第83回日本生化学会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2010-12-09
    • Related Report
      2010 Final Research Report
  • [Presentation] Perlecanによるp27の発現ならびに細胞内細胞内局在の制御を介した血管内皮細胞の増殖制御.2010

    • Author(s)
      酒井克也、松本邦夫, (他3 名)
    • Organizer
      第33回日本分子生物学会年会・第83回日本生化学会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2010-12-09
    • Related Report
      2010 Final Research Report
  • [Presentation] Pcrlecanによるp27の発現ならびに細胞内細胞内局在の制御を介した血管内皮細胞の増殖制御2010

    • Author(s)
      酒井克也、岡清正、中村隆弘、松本邦夫、中村敏一
    • Organizer
      第33回日本分子生物学会年会・日本生化学会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2010-12-09
    • Related Report
      2010 Annual Research Report
  • [Presentation] Functional analysis of the Kremen in Lewis lung carcinoma cells throughWnt/β-catenin cionalino nathwav2010

    • Author(s)
      Quing Xu, Masataka Fujikawa, Takahiro Nakamura, Kunio Matsumoto.
    • Organizer
      第33回日本分子生物学会年会・日本生化学会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2010-12-09
    • Related Report
      2010 Annual Research Report
  • [Presentation] 肝細胞におけるMet/HGF受容体Ser985リン酸化と受容体活性化の制御2010

    • Author(s)
      中山瑞穂、中村敏一, (他4名)
    • Organizer
      第33回日本分子生物学会年会・第83回日本生化学会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2010-12-08
    • Related Report
      2010 Final Research Report
  • [Presentation] 肝細胞におけるMet/HGF受容体Ser985リン酸化と受容体活性化の制御2010

    • Author(s)
      中山瑞穂、山下敦子、中村隆弘、徐慶、中村敏一、松本邦夫
    • Organizer
      第33回同本分子生物学会年会・日本生化学会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2010-12-08
    • Related Report
      2010 Annual Research Report
  • [Presentation] EGFR変異肺がんのチロシンキナーゼ阻害剤耐性と治療戦略2010

    • Author(s)
      矢野聖二、松本邦夫, (他7名)
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪府)
    • Year and Date
      2010-09-23
    • Related Report
      2010 Annual Research Report 2010 Final Research Report
  • [Presentation] Perlecanによるp27の発現ならびに細胞内細胞内局在の制御を介した血管内皮細胞の増殖制御2010

    • Author(s)
      酒井克也、松本邦夫, (他3名)
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪府)
    • Year and Date
      2010-09-22
    • Related Report
      2010 Annual Research Report 2010 Final Research Report
  • [Presentation] 野生型EGFR肺癌における肝細胞増殖因子(HGF)の抗EGFR抗体Cetuximab耐性誘導機構.2010

    • Author(s)
      山田忠明、松本邦夫、矢野聖二, (他4名)
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪府)
    • Year and Date
      2010-09-22
    • Related Report
      2010 Final Research Report
  • [Presentation] NK4による腫瘍皮下移植片中のVEGF発現抑制効果は、HGFを介する腫瘍-間質相互作用を阻害することで発揮される2010

    • Author(s)
      松村篤、松本邦夫、大辻英吾, (他10名)
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪府)
    • Year and Date
      2010-09-22
    • Related Report
      2010 Annual Research Report 2010 Final Research Report
  • [Presentation] 野生型EGFR肺癌における肝細胞増殖因子(HGF)の抗EGFR抗体Cetuximab耐性誘導機構2010

    • Author(s)
      山田忠明、竹内伸司、ドネブイワンシュテレブ、西岡安彦、曽根三郎、松本邦夫、矢野聖二
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪府)
    • Year and Date
      2010-09-22
    • Related Report
      2010 Annual Research Report
  • [Presentation] ヒト悪性中皮腫細胞のコラーゲンゲル内浸潤性増殖におけるHGF-Met系の役割とNK4による阻害2009

    • Author(s)
      鈴木芳典、松本邦夫, (他3 名)
    • Organizer
      第82回日本生化学会大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2009-10-24
    • Related Report
      2010 Final Research Report
  • [Presentation] NK4による血管新生阻害作用の解析-プロテオグリカン結合を介したフィブロネクチン構築阻害.2009

    • Author(s)
      酒井克也、松本邦夫, (他3名)
    • Organizer
      第82回日本生化学会大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2009-10-24
    • Related Report
      2010 Final Research Report
  • [Presentation] ヒト悪性中皮腫細胞のコラーゲンゲル内浸潤性増殖におけるHGF-Met系の役割とNK4による阻害2009

    • Author(s)
      鈴木芳典, 松本邦夫, 他
    • Organizer
      第82回日本生化学会大会
    • Place of Presentation
      神戸国際会議場 (兵庫県)
    • Year and Date
      2009-10-24
    • Related Report
      2009 Annual Research Report
  • [Presentation] NK4による血管新生阻害作用の解析・プロテオグリカン結合を介したフィブロネクチン構築阻害2009

    • Author(s)
      酒井克也, 松本邦夫, 他
    • Organizer
      第82回日本生化学会大会
    • Place of Presentation
      神戸国際会議場 (兵庫県)
    • Year and Date
      2009-10-24
    • Related Report
      2009 Annual Research Report
  • [Presentation] HGF-Met系を介したヒト悪性中皮腫細胞の遊走制御とMet細胞外領域遺伝子変異2009

    • Author(s)
      酒井克也、松本邦夫, (他3名)
    • Organizer
      第68回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2010 Final Research Report
  • [Presentation] NK4によるプロテオグリカン結合を介したフィブロネクチン構築阻害2009

    • Author(s)
      酒井克也、松本邦夫, (他3名)
    • Organizer
      第68回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2010 Final Research Report
  • [Presentation] CT26細胞に対するNK4遺伝子導入による5-FUのアポトーシス増強作用の検討.2009

    • Author(s)
      大場宏明、松本邦夫、大辻英吾, (他10名)
    • Organizer
      第68回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2010 Final Research Report
  • [Presentation] 血管新生阻害剤、NK4遺伝子導入によるCT26腫瘍拒絶と腫瘍特異的免疫誘導のメカニズムの検討.2009

    • Author(s)
      窪田健、松本邦夫、大辻英吾, (他10名)
    • Organizer
      第68回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2010 Final Research Report
  • [Presentation] HGF/c-Metシグナルを介したVEGF発現調節のメカニズムの検討.2009

    • Author(s)
      松村篤、松本邦夫、大辻英吾, (他10名)
    • Organizer
      第68回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2010 Final Research Report
  • [Presentation] HGF-Met系を介したヒト悪性中皮腫細胞の遊走制御とMet細胞外領域遺伝子変異2009

    • Author(s)
      鈴木芳典, 松本邦夫, 他
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜 (神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2009 Annual Research Report
  • [Presentation] NK4によるプロテオグリカン結合を介したフィブロネクチン構築阻害2009

    • Author(s)
      酒井克也, 松本邦夫, 他
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜 (神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2009 Annual Research Report
  • [Presentation] CT26細胞に対するNK4遺伝子導入による5-FUのアポトーシス増強作用の検討2009

    • Author(s)
      大場宏明, 松本邦夫, 他
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜 (神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2009 Annual Research Report
  • [Presentation] 血管新生阻害剤、NK4遺伝子導入によるCT26腫瘍拒絶と腫瘍特異的免疫誘導のメカニズムの検討2009

    • Author(s)
      窪田健, 松本邦夫, 他
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜 (神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2009 Annual Research Report
  • [Presentation] HGF/c-Metシグナルを介したVEGF発現調節のメカニズムの検討2009

    • Author(s)
      松村篤, 松本邦夫, 他
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜 (神奈川県)
    • Year and Date
      2009-10-03
    • Related Report
      2009 Annual Research Report
  • [Presentation] HGF-Met系を介した組織再生の制御と創薬2009

    • Author(s)
      松本邦夫
    • Organizer
      第24回岡山Vascular Biology研究会
    • Place of Presentation
      岡山大学(岡山県)
    • Year and Date
      2009-03-18
    • Related Report
      2010 Final Research Report
  • [Presentation] 濃度勾配因子としてのHGF を介した形態形成・細胞増殖・遊走の制御2008

    • Author(s)
      松本邦夫, (他4名)
    • Organizer
      第31回日本分子生物学会年会・第81回日本生化学会大会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2008-12-12
    • Related Report
      2010 Final Research Report
  • [Presentation] GenenaseIによってプロセッシング・活性化される組換えHGFの調製.2008

    • Author(s)
      早田大真、松本邦夫, (他5名)
    • Organizer
      第31回に本分子生物学会年会・第81回日本生化学会大会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2008-12-12
    • Related Report
      2010 Final Research Report
  • [Presentation] Genenase Iによってプロセッシング・活性イヒされる組換えHGFの調製.2008

    • Author(s)
      早田大真, 松本邦夫, 他
    • Organizer
      第31回日本分子生物学会年会・第81回日本生化学会合同大会
    • Place of Presentation
      神戸
    • Year and Date
      2008-12-12
    • Related Report
      2008 Annual Research Report
  • [Presentation] 濃度勾配因子としてのHGFを介した形態形成・細胞増殖・遊走の制御2008

    • Author(s)
      松本邦夫, 他
    • Organizer
      第31回日本分子生物学会年会・第81回日本生化学会合同大会
    • Place of Presentation
      神戸
    • Year and Date
      2008-12-12
    • Related Report
      2008 Annual Research Report
  • [Presentation] マトリックスメタロプロテアーゼに依存したヒト悪性中皮腫のコラーゲンマトリックス内浸潤.2008

    • Author(s)
      酒井克也、松本邦夫, (他3名)
    • Organizer
      第31回に本分子生物学会年会・第81回日本生化学会大会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2008-12-10
    • Related Report
      2010 Final Research Report
  • [Presentation] ヒト悪性中皮腫の浸潤性増殖におけるHGF-Met系の意義とNK4による阻止.2008

    • Author(s)
      鈴木芳典、松本邦夫, (他2名)
    • Organizer
      第31回に本分子生物学会年会・第81回日本生化学会大会合同大会
    • Place of Presentation
      神戸ポートアイランド(兵庫県)
    • Year and Date
      2008-12-09
    • Related Report
      2010 Final Research Report
  • [Presentation] ヒト悪性中皮腫の浸潤性増殖におけるHGF-Met系の意義とNK4による阻止.2008

    • Author(s)
      鈴木芳典, 松本邦夫, 他
    • Organizer
      第31回日本分子生物学会年会・第81回日本生化学会合同大会
    • Place of Presentation
      神戸
    • Year and Date
      2008-12-09
    • Related Report
      2008 Annual Research Report
  • [Presentation] MMPに依存したヒト悪性中皮腫のコラーゲンマトリックス内浸潤.2008

    • Author(s)
      酒井克也, 松本邦夫, 他
    • Organizer
      第31回日本分子生物学余年会・第81回日本生化学会合同大会
    • Place of Presentation
      神戸
    • Year and Date
      2008-12-09
    • Related Report
      2008 Annual Research Report
  • [Presentation] NK4遺伝子導入CT26腫瘍における血管新生阻害とCD8+T細胞誘導のメカニズムの検討.2008

    • Author(s)
      窪田健、松本邦夫、大辻英吾, (他9名)
    • Organizer
      第67回日本癌学会総会
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2008-10-29
    • Related Report
      2010 Final Research Report
  • [Presentation] ヒト悪性中皮腫に対する浸潤性増殖ならびに血管新生害を介したNK4の制癌作用.2008

    • Author(s)
      鈴木芳典、松本邦夫, (他2名)
    • Organizer
      第67回日本癌学会総会
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2008-10-29
    • Related Report
      2010 Final Research Report
  • [Presentation] NK4遺伝子導入CT26腫瘍における血管新生阻害とCD8+T細胞誘導のメカニズムの検討2008

    • Author(s)
      窪田健, 松本邦夫, 他
    • Organizer
      第67回日本癌学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2008-10-29
    • Related Report
      2008 Annual Research Report
  • [Presentation] ヒト悪性中皮腫に対する浸潤性増殖ならびに血管新生阻害を介したNK4の制癌作用.2008

    • Author(s)
      鈴木芳典, 松本邦夫, 他
    • Organizer
      第67回日本癌学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2008-10-29
    • Related Report
      2008 Annual Research Report
  • [Presentation] マトリックスメタロプロテアーゼに依存したヒト悪性中皮腫のコラーゲンマトリックス内浸潤.2008

    • Author(s)
      酒井克也、松本邦夫, (他3名)
    • Organizer
      第67回日本癌学会総会
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2008-10-28
    • Related Report
      2010 Final Research Report
  • [Presentation] "Significance of HGF-Met in cancer malignancy and therapeutic approach with NK4" International Session 6 : Chemokine, Cytokine and Cancer2008

    • Author(s)
      松本邦夫
    • Organizer
      第67回日本癌学会総会
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2008-10-28
    • Related Report
      2010 Final Research Report
  • [Presentation] Significance of HGF-Met in cancer malignancy and therapeutic approach with NK42008

    • Author(s)
      松本邦夫
    • Organizer
      第67回日本癌学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2008-10-28
    • Related Report
      2008 Annual Research Report
  • [Presentation] マトリツクスメタロプロテアーゼに依存したヒト悪性中皮腫のコラーゲン内浸潤.2008

    • Author(s)
      酒井克也, 松本邦夫, 他
    • Organizer
      第67回日本癌学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2008-10-28
    • Related Report
      2008 Annual Research Report
  • [Presentation] Inhibition of tumor metastasis and angiogenesis by NK4, bifunctional inhibitor of HGF-Met and angiogenesis2008

    • Author(s)
      Kunio Matsumoto
    • Organizer
      EHRLICH II World Conference on Magic Bullets
    • Place of Presentation
      (Niirnberg, Germany)
    • Year and Date
      2008-10-04
    • Related Report
      2008 Annual Research Report
  • [Presentation] Inhibition of tumor metastasis and angiogenesis by NK4, bifunctional inhibitor of HGF-Met and angiogenesis2008

    • Author(s)
      松本邦夫
    • Organizer
      EHRLICH II World Conference on Magic Bullets.
    • Place of Presentation
      Meistersingerhalle Nurnberg(Germany)
    • Related Report
      2010 Final Research Report
  • [Book] In"Cancer Treatment"(Significance, mechanisms, and progress of anticancer drugs targeting HGF-Met)2011

    • Author(s)
      Sakai K, Nakamura T, Suzuki Y, Matsumoto K
    • Publisher
      InTech Open Access Publisher, in press
    • Related Report
      2010 Final Research Report
  • [Book] 遺伝子医学MOOK別冊「ますます重要になる細胞周辺環境の科学技術」2010

    • Author(s)
      中山瑞穂, 松本邦夫
    • Publisher
      メディカルドウ(印刷中)
    • Related Report
      2009 Annual Research Report
  • [Book] バイオ医薬開発技術とシーズ(山本重夫監修・(株))(新規がん分子標的薬-NK4(HGF アンタゴニスト/血管新生阻害分子)の開発-)2009

    • Author(s)
      福田一弘、松本邦夫、中村敏一
    • Publisher
      シーエムシー出版
    • Related Report
      2010 Final Research Report
  • [Book] 炎症・再生医学事典(松島剛治・西脇徹編)(HGF)2009

    • Author(s)
      中村隆弘、松本邦夫
    • Publisher
      朝倉書店
    • Related Report
      2010 Final Research Report
  • [Book] 遺伝子医学MOOK別冊「ますます重要になる細胞周辺環境の科学技術」(田畑泰彦編)(細胞増殖因子)2009

    • Author(s)
      中山瑞穂、松本邦夫
    • Publisher
      メディカルドウ
    • Related Report
      2010 Final Research Report
  • [Book] がん分子標的治療(HGF研究の進展と制癌剤開)2009

    • Author(s)
      中村隆弘、櫻間晴子、中村敏一、松本邦夫
    • Publisher
      メディカルレビュー社
    • Related Report
      2010 Final Research Report
  • [Book] Surgery Frontier(癌の発生,浸潤,転移における腫瘍関連線維芽細胞(cacer-associated fibroblast)の役割)2009

    • Author(s)
      鈴木芳典、松本邦夫
    • Related Report
      2010 Final Research Report
  • [Book] “新規がん分子標的薬- NK4(HGFアンタゴニスト/血管新生阻害分子)の開発"、「バイオ医薬開発技術とシース」2009

    • Author(s)
      福田一弘, 松本邦夫, 他(分担分)
    • Total Pages
      13
    • Publisher
      シーェムシー出版
    • Related Report
      2008 Annual Research Report
  • [Book] “HGF"、「炎症・再生医学事典」2009

    • Author(s)
      中村隆弘, 松本邦夫
    • Publisher
      朝倉書店(印刷中)
    • Related Report
      2008 Annual Research Report
  • [Book] “細胞増殖因子"、「ますます重要になる細胞周辺環境の科学技術」2009

    • Author(s)
      中山瑞穂, 松本邦夫
    • Publisher
      朝倉書店(印刷中)
    • Related Report
      2008 Annual Research Report
  • [Book] がんはなぜできるのか(シリーズ新・がん医学入門(2))(谷口直之・杉山治夫・松浦成昭編)(細胞増殖・細胞死の制御異常)2008

    • Author(s)
      松本邦夫、鈴木芳典
    • Publisher
      中山書店
    • Related Report
      2010 Final Research Report
  • [Book] 分子細胞生物学辞典(第2版)(東京化学同人)(肝細胞増殖因子)2008

    • Author(s)
      松本邦夫
    • Related Report
      2010 Final Research Report
  • [Book] “細胞増殖・細胞死の制御異常"、「がん医学人門」2008

    • Author(s)
      松本邦夫, 他(分担分)
    • Total Pages
      17
    • Publisher
      中山言店
    • Related Report
      2008 Annual Research Report
  • [Book] “肝細胞増殖因子"、「分子細胞生物学辞典(第2版)」2008

    • Author(s)
      松本邦夫, 他(分担分)
    • Total Pages
      1
    • Publisher
      東京化学同人
    • Related Report
      2008 Annual Research Report
  • [Remarks]

    • URL

      http://www.kanazawa-u.ac.jp/~ganken/shuyoudoutaiseigyo/index.html

    • Related Report
      2010 Final Research Report
  • [Patent(Industrial Property Rights)] 分子標的薬に対する感受性が低下している癌の治療薬および分子標的薬に対する感受性を増強する医薬組成物2009

    • Inventor(s)
      矢野聖二、松本邦夫
    • Industrial Property Rights Holder
      金沢大学
    • Industrial Property Number
      2009-078621
    • Filing Date
      2009-03-27
    • Related Report
      2010 Final Research Report
  • [Patent(Industrial Property Rights)] 「分子標的薬に対する感受性が低下している癌の治療薬および分子標的薬に対する感受性を増強する医薬組成物」2009

    • Inventor(s)
      矢野聖二松本邦夫
    • Industrial Property Rights Holder
      国立大学法人金沢大学
    • Industrial Property Number
      2009-078621
    • Filing Date
      2009-03-27
    • Related Report
      2008 Annual Research Report
  • [Patent(Industrial Property Rights)] 骨延長促進剤2008

    • Inventor(s)
      冨田勝郎、土屋弘行、松原秀憲、花田敬吾、松本邦夫
    • Filing Date
      2008-07-18
    • Related Report
      2010 Final Research Report
  • [Patent(Industrial Property Rights)] 腱骨移行部組織または靭帯骨移行部組織の再生促進剤2008

    • Inventor(s)
      冨田勝郎、土屋弘行、松原秀憲、花田敬吾、松本邦夫
    • Filing Date
      2008-10-10
    • Related Report
      2010 Final Research Report
  • [Patent(Industrial Property Rights)] 「骨延長促進剤」2008

    • Inventor(s)
      富田勝郎土屋弘行松原秀憲花田敬吾松本邦夫
    • Industrial Property Rights Holder
      クリングルフアーマ株式会社
    • Filing Date
      2008-07-18
    • Related Report
      2008 Annual Research Report
  • [Patent(Industrial Property Rights)] 「腱骨移行部組織または靭帯骨移行部組織の再生促進剤」2008

    • Inventor(s)
      富田勝郎北岡克彦中瀬順介花田敬吾松本邦夫
    • Industrial Property Rights Holder
      クリングルフアーマ株式会社
    • Filing Date
      2008-10-10
    • Related Report
      2008 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi